Table 2.
No death (n = 268) | Death (n = 142) | p | |
---|---|---|---|
Mean age in years (SD) | 67.4 (13.8) | 77 (12) | <0.001 |
Age groups | |||
Under 65 | 113 (85.6%) | 19 (14.4%) | <0.001 |
Between 65 and 75 years | 67 (65%) | 36 (35%) | |
Between 75 and 85 years | 64 (56.6%) | 49 (43.4%) | |
More than 85 years | 24 (38.7%) | 38 (61.3%) | |
Sex | |||
Male | 131 (64.9%) | 71 (35.1%) | 0.829 |
Female | 137 (65.9%) | 71 (34.1%) | |
Barthel | |||
> 60 | 225 (70.5%) | 94 (29.5%) | <0.001 |
≤ 60 | 27 (45.8%) | 32 (54.2%) | |
Not available | – | – | |
Charlson | |||
< 3 | 230 (71.2%) | 93 (28.8%) | <0.001 |
= > | 38 (43.7%) | 49 (56.3%) | |
Obesity | |||
Yes | 51 (58%) | 37 (42%) | 0.099 |
No | 217 (67.4%) | 105 (32.6%) | |
Respiratory disease | |||
Chronic | |||
Yes | 86 (59.3%) | 59 (40.7%) | 0.057 |
No | 182 (68.7%) | 83 (31.3%) | |
Ischemic Heart Disease / Heart Failure | |||
Yes | 22 (44%) | 28 (56%) | <0.001 |
No | 246 (68.3%) | 114 (31.7%) | |
Renal failure | |||
Yes | 23 (46.9%) | 26 (53.1%) | 0.004 |
No | 245 (67.9%) | 116 (32.1%) | |
Chronic liver disease | |||
Yes | 5 (71.4%) | 2 (28.6%) | 0.999 |
No | 263 (65.3%) | 140 (34.7%) | |
Hematologic malignancy | |||
Yes | 4 (44.4%) | 5 (55.6%) | 0.286 |
No | 264 (65.8%) | 137 (34.2%) | |
Other neoplasms | |||
Yes | 11 (36.7%) | 189 (63.3%) | 0.001 |
No | 257 (67.6%) | 123 (32.4%) | |
Diabetes | |||
Yes | 68 (62.4%) | 41 (37.6%) | 0.445 |
No | 200 (66.4%) | 101 (33.6%) | |
HBP | |||
Yes | 148 (57.8%) | 108 (42.2%) | <0.001 |
No | 120 (77.9%) | 34 (22.1%) | |
Cognitive impairment | |||
Yes | 29 (59.2%) | 20 (40.8%) | 0.332 |
No | 239 (66.2%) | 122 (33.8%) | |
Other neurological diseases | |||
Yes | 58 (60.4%) | 38 (39.6%) | 0.244 |
No | 210 (66.9%) | 104 (33.1%) | |
Depressive syndrome | |||
Yes | 35 (57.4%) | 26 (42.6%) | 0.155 |
No | 233 (66.8%) | 116 (33.2%) | |
Heart failure during admission | |||
Yes | 3 (15%) | 17 (85%) | <0.001 |
No | 265 (67.9%) | 125 (32.1%) | |
Cardiovascular event during admission | |||
Yes | 2 (33.3%) | 4 (66.7%) | 0.190 |
No | 262 (65.5%) | 138 (34.5%) | |
Immunosuppressive treatment | |||
Yes | 9 (64.3%) | 5 (35.7%) | 0.999 |
No | 259 (65.4%) | 137 (34.6%) | |
Institutionalized | |||
Yes | 15 (46.9%) | 17 (53.1%) | 0.022 |
No | 253 (66.9%) | 125 (33.1%) | |
Influenza vaccine | |||
Yes | 116 (55.5%) | 93 (44.5%) | <0.001 |
No | 152 (75.6%) | 49 (24.4%) | |
ICU admission | |||
Yes | 14 (58.3%) | 10 (41.7%) | 0.456 |
No | 254 (65.8%) | 132 (34.2%) |